Page last updated: 2024-11-07

asiatic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Asiatic acid is a triterpenoid compound found in the Centella asiatica plant. It is known for its wound-healing, anti-inflammatory, and antioxidant properties. Research suggests that asiatic acid may promote collagen synthesis, improve blood circulation, and protect against nerve damage. It is being studied for its potential therapeutic applications in treating skin conditions like acne, burns, and ulcers, as well as neurological disorders and inflammatory diseases. The compound is typically extracted from the plant or synthesized in the laboratory. Its potential to regenerate tissues and its anti-inflammatory effects are driving ongoing research into its various applications.'

FloraRankFlora DefinitionFamilyFamily Definition
Symplocosgenus[no description available]Symplocaceae[no description available]
Vateriagenus[no description available]DipterocarpaceaeA plant family of the order ERICALES.[MeSH]
CentellagenusA plant of the family APIACEAE which is the source of asiatic acid and asiaticoside. Centella asiatica (L.) Urb. = Hydrocotyle asiatica L. is known for effect on peripheral circulation.[MeSH]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]
Symplocos lancifoliaspecies[no description available]Symplocaceae[no description available]
Vateria indicaspecies[no description available]DipterocarpaceaeA plant family of the order ERICALES.[MeSH]
Vateria indicaspecies[no description available]DipterocarpaceaeA plant family of the order ERICALES.[MeSH]
Centella asiaticaspecies[no description available]ApiaceaeA large plant family in the order Apiales, also known as Umbelliferae. Most are aromatic herbs with alternate, feather-divided leaves that are sheathed at the base. The flowers often form a conspicuous flat-topped umbel. Each small individual flower is usually bisexual, with five sepals, five petals, and an enlarged disk at the base of the style. The fruits are ridged and are composed of two parts that split open at maturity.[MeSH]

Cross-References

ID SourceID
PubMed CID119034
CHEMBL ID404313
CHEBI ID2873
SCHEMBL ID3285999
MeSH IDM0067469

Synonyms (60)

Synonym
464-92-6
asiatic acid ,
C08617
nsc-166063
asiantic acid
asiatic acid, 97%
0as ,
bdbm50241487
chebi:2873 ,
CHEMBL404313 ,
2,3,23-trihydroxyurs-12-en-28-oic acid
(1s,2r,4as,6ar,6as,6br,8ar,9r,10r,11r,12ar,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid
AKOS007930256
urs-12en-28-oic acid, 2,3,23-trihydroxy-, (2alpha, 3beta, 4alpha)-
hsdb 7662
urs-12-en-28-oic acid, 2,3,23-trihydroxy-, (2alpha,3beta,4alpha)-
9pa5a687x5 ,
unii-9pa5a687x5
nsc 166063
(2alpha,3beta)-2,3,23-trihydroxyurs-12-en-28-oic acid
CCG-208549
asiatic acid (constituent of banaba leaf) [dsc]
asiatic acid (constituent of holy basil leaf) [dsc]
asiatic acid [inci]
asiatic acid [who-dd]
asiatic acid [hsdb]
asiatic acid (constituent of centella asiatica) [dsc]
(2.alpha.,3.beta.,4.alpha.)-2,3,23-trihydroxyurs-12-en-28-oic acid
dammarolic acid
SCHEMBL3285999
asiaticacid
Q-100489
asiatic-acid
urs-12-en-28-oic acid, 2,3,23-trihydroxy-, (2.alpha.,3.beta.,4.alpha.)-
mfcd00238541
asiatic acid, analytical standard
asiatic acid, >=98% (hplc), from centella asiatica
(1s,2r,4as,6ar,6as,6br,8ar,9r,10r,11r,12ar,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1h-picene-4a-carboxylicacid
esculentic acid (diplazium)
NCGC00346584-02
(1s,2r,4as,6as,6br,8ar,9r,10r,11r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid
(2alpha,3beta,5beta,20beta)-2,3,23-trihydroxyurs-12-en-28-oic acid
DB14054
Q15478109
DTXSID901019207 ,
BRD-K35079116-001-03-3
CS-0007893
HY-N0194
(4i+/-)-a?i+/-,a?i(2),a?3-atrihydroxy-aurs-a?2-aen-a?8-aoic acid
urs-12-en-28-oic acid, 2,3,23-trihydroxy-, (2a,3b,4a)-
(1s,2r,4as,6as,6br,8ar,9r,12ar,12br,14bs)-10,11-dihydroxy-9-(hydroxymethyl)-1,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydropicene-4a(2h)-carboxylic acid
A936485
(4alpha)-2alpha,3beta,23-trihydroxy-urs-12-en-28-oic acid
A2475
asiatic acid (constituent of centella asiatica)
dtxcid601477197
2alpha,3beta,23-trihydroxyurs-12-en-28-oic acid
asiatic acid (constituent of banaba leaf)
asiatic acid (constituent of holy basil leaf)
(2alpha,3beta,4alpha)-2,3,23-trihydroxyurs-12-en-28-oic acid

Research Excerpts

Overview

Asiatic acid (AA) is a naturally pentacyclic triterpenoids extracted from traditional medicine Centella asiatica l. It has been suggested to possess free radical scavenging and anti-apoptotic properties.

ExcerptReferenceRelevance
"Asiatic acid (AA) is a triterpenoid derivate with antifibrotic properties."( Asiatic Acid Improves Extracellular Matrix Remodeling in Vocal Fold Scarring Via SMAD7 Activation.
Jiang, JJ; Li, P; Li, W; Liu, D; Qian, T; Sun, S, 2022
)
2.89
"Asiatic acid (AA) is a natural compound and has been explored due to its anti-glioma activity and lower toxicity to healthy tissues compared with conventional chemotherapeutic agents."( Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.
Bravo, M; Lima, J; Loureiro, JA; Pereira, MC; Ramalho, MJ, 2022
)
1.68
"Asiatic acid (AA) is a naturally pentacyclic triterpenoids extracted from traditional medicine Centella asiatica l. "( Asiatic acid from centella asiatica exert anti-invasive ability in human renal cancer cells by modulation of ERK/p38MAPK-mediated MMP15 expression.
Hsieh, YH; Huang, CF; Hung, TW; Lin, CL; Tsai, YL; Yang, JT; Yang, SF, 2022
)
3.61
"Asiatic acid is a pentacyclic triterpene enriched in the medicinal herb Centella asiatica, and it has been suggested to possess free radical scavenging and anti-apoptotic properties. "( Asiatic acid supplementation during the in vitro culture period improves early embryonic development of porcine embryos produced by parthenogenetic activation, somatic cell nuclear transfer and in vitro fertilization.
Bai, CY; Diao, YF; Li, XX; Liang, S; Liu, PL; Qi, JJ; Sun, BX; Wang, DL; Yuan, B, 2020
)
3.44
"Asiatic acid (AA) is a triterpenoid isolated from"( Preparation and evaluation of PEGylated asiatic acid nanostructured lipid carriers on anti-fibrosis effects.
Chen, X; Chen, Y; Wang, S; Yin, L; Zhang, Y; Zhao, P; Zhou, Y, 2020
)
1.55
"Asiatic acid proved to be a potent and effective drug in the rat model of CYP-induced cystitis."( The Potential of Asiatic Acid in the Reversion of Cyclophosphamide-Induced Hemorrhagic Cystitis in Rats.
Gold, D; Juszczak, K; Kluz, T; Misiek, M; Poleszak, E; Radziszewski, P; Rogowski, A; Sieńko, J; Stangel-Wójcikiewicz, K; Wróbel, A; Zapała, Ł, 2021
)
1.68
"Asiatic acid is a natural triterpene found in Centella asiatica that acts as an effective free radical scavenger. "( Supplementation with asiatic acid during in vitro maturation improves porcine oocyte developmental competence by regulating oxidative stress.
Diao, YF; Hu, WY; Jiang, H; Li, XX; Liang, S; Qi, JJ; Sun, BX; Wang, DL; Zhang, JB; Zhang, Y, 2021
)
2.38
"Asiatic acid (AA) is a triterpenoid, isolated from Centella asiatica, exhibiting efficient anti-inflammatory and anti-oxidative activities."( Asiatic acid ameliorates pulmonary fibrosis induced by bleomycin (BLM) via suppressing pro-fibrotic and inflammatory signaling pathways.
Dong, SH; Han, ZD; Liu, YW; Tan, HZ; Wei, F, 2017
)
2.62
"Asiatic acid (AA) is a triterpene compound found in Centella asiatica that can protect against reduction of neurogenesis in the hippocampus and memory deficits induced by valproic acid (VPA)."( Asiatic acid protects against cognitive deficits and reductions in cell proliferation and survival in the rat hippocampus caused by 5-fluorouracil chemotherapy.
Chaijaroonkhanarak, W; Chaisawang, P; Pannangrong, W; Sirichoat, A; Sripanidkulchai, B; Welbat, JU; Wigmore, P, 2017
)
2.62
"Asiatic acid (AA) is a pentacyclic triterpene in Centella asiatica known to inhibit proliferation and induce apoptosis in several tumor cell lines. "( Antiproliferative, cell-cycle dysregulation effects of novel asiatic acid derivatives on human non-small cell lung cancer cells.
Feng, B; Wang, L; Xu, J; Zhao, C; Zhao, L, 2013
)
2.07
"Asiatic acid is a triterpenoid isolated from Centella asiatica. "( Asiatic acid alleviates hemodynamic and metabolic alterations via restoring eNOS/iNOS expression, oxidative stress, and inflammation in diet-induced metabolic syndrome rats.
Bunbupha, S; Khrisanapant, W; Kukongviriyapan, U; Kukongviriyapan, V; Pakdeechote, P; Prachaney, P, 2014
)
3.29
"Asiatic acid (AA) is a triterpenoid compound extracted from Centella asiatica and exhibits a variety of pharmacological effects."( Asiatic acid attenuates cardiac hypertrophy by blocking transforming growth factor-β1-mediated hypertrophic signaling in vitro and in vivo.
Gu, W; Si, L; Wang, F; Wang, X; Xu, J; Xu, X; Yi, C; Zhang, Y, 2014
)
2.57
"Asiatic acid (AA) is a pleiotropic neuroprotective agent that has been shown to attenuate infarct volume in mouse and rat models of focal ischemia and has a long clinically relevant therapeutic time-window. "( Neuroprotective effect of asiatic acid in rat model of focal embolic stroke.
Bae, ON; Kassab, M; Lee, KY; Majid, A; Weinstock, S, 2014
)
2.15
"Asiatic acid (1) is a natural triterpenoid isolated from Centella asiatica. "( Unusual microbial lactonization and hydroxylation of asiatic acid by Umbelopsis isabellina.
Dong, XR; Gao, RR; Gao, ZH; Sun, DA, 2015
)
2.11
"Asiatic acid is a pentacyclic triterpene from Centella asiatica. "( Effects of Asiatic Acid on Spatial Working Memory and Cell Proliferation in the Adult Rat Hippocampus.
Chaichun, A; Chaijaroonkhanarak, W; Leksomboon, R; Pannangrong, W; Prachaney, P; Sirichoat, A; Welbat, JU; Wigmore, P, 2015
)
2.25
"Asiatic acid (AA) is a triterpenoid compound extracted from Centella asiatica that exhibits antiapoptotic, antifibrotic, and anti-inflammatory activities."( Asiatic Acid Attenuates the Progression of Left Ventricular Hypertrophy and Heart Failure Induced by Pressure Overload by Inhibiting Myocardial Remodeling in Mice.
Ma, C; Si, L; Wang, F; Wang, X; Xu, J; Xu, X; Yang, J; Yi, C; Zhang, Y, 2015
)
2.58
"Asiatic acid (AA) is a triterpene extracted from Centella asiatica has been reported as an antioxidant and anti-inflammatory agent, that offers neuroprotection against glutamate toxicity."( Neuroprotective effect of asiatic acid on rotenone-induced mitochondrial dysfunction and oxidative stress-mediated apoptosis in differentiated SH-SYS5Y cells.
Essa, MM; Justin Thenmozhi, A; Manivasagam, T; Nataraj, J, 2017
)
1.48
"Asiatic acid is a major triterpene isolated from Centella asiatica (L.) Urban and has been shown to possess anti-oxidant, anti-hyperlipidemia and anti-inflammatory activities."( Barrier protective effect of asiatic acid in TNF-α-induced activation of human aortic endothelial cells.
Ahmad, Z; Cheok, ZL; Fong, LY; Hakim, MN; Mohd Moklas, MA; Ng, CT, 2016
)
1.45
"Asiatic acid is a natural phytochemical with oxidant, antioxidant and anti-inflammatory properties with emerging anti-malarial potential."( Pre-infection administration of asiatic acid retards parasitaemia induction in Plasmodium berghei murine malaria infected Sprague-Dawley rats.
Mabandla, MV; Mavondo, GA; Mkhwananzi, BN, 2016
)
1.44
"Asiatic acid is a triterpenoid derived from the medicinal plant Centella asiatica."( Asiatic Acid Prevents the Deleterious Effects of Valproic Acid on Cognition and Hippocampal Cell Proliferation and Survival.
Chaijaroonkhanarak, W; Pakdeechote, P; Pannangrong, W; Prachaney, P; Sirichoat, A; Sripanidkulchai, B; Umka Welbat, J; Wigmore, P, 2016
)
2.6
"Asiatic acid is a natural phytochemical with oxidant, antioxidant and anti-inflammatory properties whose effect on malarial and accompanying pathophysiology are yet to be investigated."( Asiatic acid influences parasitaemia reduction and ameliorates malaria anaemia in P. berghei infected Sprague-Dawley male rats.
Mabandla, MV; Mavondo, GA; Mkhwananzi, BN; Musabayane, CT, 2016
)
2.6
"Asiatic acid is a triterpenoid component possessing antioxidative, anti-inflammatory and hepatoprotective activity. "( Protective effects of asiatic acid against D-galactosamine/lipopolysaccharide-induced hepatotoxicity in hepatocytes and kupffer cells co-cultured system via redox-regulated leukotriene C4 synthase expression pathway.
Lou, Y; Ma, K; Zhang, Y; Zhu, D, 2009
)
2.11
"Asiatic acid is a major pentacyclic triterpene isolated from Centella asiatica. "( Microbial transformation of asiatic acid by Alternaria longipes.
Dai, JG; Guo, DA; He, WN; Wu, LJ; Ye, M, 2010
)
2.1
"Asiatic acid (AA) is a natural triterpenoid possessing anti-inflammatory, anticancer, neuroprotective, and hepatoprotective activities. "( Two new oxidation products obtained from the biotransformation of asiatic acid by the fungus Fusarium avenaceum AS 3.4594.
Guo, DA; He, WN; Huang, FX; Lin, XH; Song, W; Yang, WZ; Ye, M, 2012
)
2.06
"Asiatic acid (AA) is a pentacyclic triterpene found in Centella asiatica. "( Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells.
Bosire, KO; Kim, JA; Lee, ES; Lee, YS; Park, BC, 2005
)
3.21
"Asiatic acid is a pentacyclic triterpene contained in medicinal plants. "( Inhibitory effects of asiatic acid and CPT-11 on growth of HT-29 cells.
Arimochi, H; Bunpo, P; Kataoka, K; Kuwahara, T; Nakayama, H; Ohnishi, Y; Vinitketkumnuen, U, 2005
)
2.09
"Asiatic acid (AA) is a member of the ursane family of triterpenoids and has anticancer activity, but its mechanism of action is not completely understood."( Disruption of the endoplasmic reticulum and increases in cytoplasmic calcium are early events in cell death induced by the natural triterpenoid Asiatic acid.
Berube, C; Chow, S; Gronda, M; Gurfinkel, DM; Hedley, DW; Henderson, C; Hurren, R; Schimmer, AD, 2006
)
1.26

Effects

Asiatic acid (AA) has been reported to provide cardioprotection against several cardiovascular diseases. It has been suggested to inhibit pulmonary and hepatic fibrosis, while its influence on cardiac fibrosis remains unclear.

ExcerptReferenceRelevance
"Asiatic acid has a binding affinity for IGF-1R signaling."( Asiatic acid in
Ariani, A; Ghofar, IF; Khotimah, H; Nurdiana, N; Rahayu, M, 2023
)
3.07
"Asiatic acid (AA) has demonstrated renal protective effects in DKD; however, its therapeutic effect on tubular injury in DKD remains unclear."( Asiatic acid attenuates tubular injury in diabetic kidney disease by regulating mitochondrial dynamics via the Nrf-2 pathway.
Chen, J; Fang, S; Ji, Y; Jiang, C; Liu, J; Pan, K; Song, S; Wang, L; Wang, Z; Xu, S; Xu, Y; Yin, Z; Zhang, J; Zhang, X, 2023
)
3.07
"Asiatic acid has a binding affinity for IGF-1R signaling."( Asiatic acid in
Ariani, A; Ghofar, IF; Khotimah, H; Nurdiana, N; Rahayu, M, 2023
)
3.07
"Asiatic acid has multiple health-protecting effects because of its variety biological function."( Asiatic acid ameliorates life and health span in fruit fly.
Liu Ming, -; Liu Xianchu, -; Peng Huan, -, 2023
)
3.07
"Asiatic acid (AA) has been reported to provide cardioprotection against several cardiovascular diseases."( Asiatic Acid Protects against Doxorubicin-Induced Cardiotoxicity in Mice.
Hu, X; Li, B; Li, L; Luo, J; Shen, B, 2020
)
2.72
"Asiatic acid (AA) has been demonstrated to exhibit anti-diabetic activity. "( Protective effects of asiatic acid in a spontaneous type 2 diabetic mouse model.
Fan, Y; Guo, X; Han, L; Hou, Y; Liu, T; Luo, G; Ma, X; Matsabisa, M; Qin, L; Sun, W; Wu, L; Xu, G; Xu, T; Zhou, J, 2017
)
2.21
"Asiatic acid (AA) has been reported have the functions of anti-inflammation and anti-apoptosis, etc."( Asiatic acid protects against cisplatin-induced acute kidney injury via anti-apoptosis and anti-inflammation.
An, N; Guo, Y; Huang, TS; Huang, XJ; Liu, HF; Pan, Q; Tang, HX; Xu, YZ; Yang, C; Zhao, J, 2018
)
2.64
"Asiatic acid (AA) has been suggested to inhibit pulmonary and hepatic fibrosis, while its influence on cardiac fibrosis remains unclear. "( Asiatic acid inhibits cardiac fibrosis throughNrf2/HO-1 and TGF-β1/Smads signaling pathways in spontaneous hypertension rats.
Li, HY; Liu, YZ; Meng, Z; Si, CY; Teng, S, 2019
)
3.4
"Asiatic acid has very weak chromophore so high-pressure liquid chromatography-based novel pre-derivatization method was developed using p-toluidine as a coupling agent to improve sensitivity."( Development of glutathione-conjugated asiatic acid-loaded bovine serum albumin nanoparticles for brain-targeted drug delivery.
Acharya, N; Acharya, S; Mistry, T; Raval, N, 2015
)
1.41
"Asiatic acid (AA) has been used as an anti-inflammatory and anti-oxidant agent in Eastern countries for many years."( Effect of Asiatic Acid on the Treatment of Spinal Cord Injury: An Experimental Study in Rats.
Bavbek, M; Bodur, E; Gurcan, O; Gurcay, AG; Karaca, EU; Kazanci, A; Senturk, S; Turkoglu, OF, 2017
)
1.58
"Asiatic acid (AA) has been shown to attenuate cerebral infarction in a mouse model of focal ischemia and shows promise as a neuroprotective stroke therapy. "( Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia.
Bae, ON; Baek, SH; Fitzgerald, SD; Goudreau, J; Hejabian, S; Kassab, M; Lee, KY; Majid, A; Moussa, A; Reeves, M; Rumbeiha, W; Serfozo, K; Stein, G, 2012
)
3.26

Treatment

Asiatic acid treatment triggered the mitochondrial apoptotic pathway indicated by changing Bax/Bcl-2 ratios, cytochrome c release, and caspase-9 activation. Pretreatment with ursolic acid significantly reduced the UVA-induced activation and expression of MMP-2.

ExcerptReferenceRelevance
"Asiatic acid pretreatment significantly improved the cardiac function indexes, attenuated the size of myocardial infarction, reduced LDH and CK activities, and suppressed cardiomyocyte apoptosis after MI/R. "( Asiatic acid protests against myocardial ischemia/reperfusion injury via modulation of glycometabolism in rat cardiomyocyte.
Dai, Y; Li, Y; Lv, Y; Qian, Y; Quan, M; Wang, Z; Xin, HB, 2018
)
3.37
"Asiatic acid-treated cells showed a cell cycle arrest at the G0/G1 phase and 7- to 10-fold increase in apoptosis."( Asiatic acid exerts anticancer potential in human ovarian cancer cells via suppression of PI3K/Akt/mTOR signalling.
Cao, QX; Ren, L; Yang, SQ; Zhai, FR; Zhang, HX, 2016
)
2.6
"Asiatic acid treatment triggered the mitochondrial apoptotic pathway indicated by changing Bax/Bcl-2 ratios, cytochrome c release, and caspase-9 activation, but it did not act on Fas/Fas ligand pathways and the activation of caspase-8."( Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells.
Hsu, YL; Kuo, PL; Lin, CC; Lin, LT, 2005
)
2.49
"Pretreatment with asiatic acid or ursolic acid significantly reduced the UVA-induced activation and expression of MMP-2."( Inhibition of ultraviolet-A-modulated signaling pathways by asiatic acid and ursolic acid in HaCaT human keratinocytes.
Beak, SM; Jin, DQ; Kim, JA; Lee, ES; Soo Lee, Y, 2003
)
0.88

Toxicity

ExcerptReferenceRelevance
" RESULTS In zebrafish, the toxicity of AA-PMe was lower than AA, with an acute toxic dose of AA-PMe above 25 μM, compared to acute toxicity at doses above 10 μM for AA."( Assessment of Toxicity and Absorption of the Novel AA Derivative AA-Pme in SGC7901 Cancer Cells In Vitro and in Zebrafish In Vivo.
Gong, Z; Jing, Y; Wang, G; Wei, Y; Wu, W; Wu, Y; Xiao, Q, 2018
)
0.48
" No systemic adverse effect of AA-PLGA NPs was observed in our studies."( Synthesis, characterization, and evaluation of in vitro cytotoxicity and in vivo antitumor activity of asiatic acid-loaded poly lactic-co-glycolic acid nanoparticles: A strategy of treating breast cancer.
Basak, S; Chakraborty, P; Chatterjee, S; Dewanjee, S; Dutta, S; Ghosh, N; Ghosh, S; Sil, PC, 2022
)
0.94

Pharmacokinetics

Plasma concentrations of asiatic acid were determined at designated points. Main pharmacokinetic parameters were estimated.

ExcerptReferenceRelevance
" However, after chronic treatment with both 30 and 60 mg, peak plasma concentrations, AUC0-24 and half-life were significantly higher than those observed after the corresponding single dose administration."( Pharmacokinetics of the total triterpenic fraction of Centella asiatica after single and multiple administrations to healthy volunteers. A new assay for asiatic acid.
Caravaggi, M; Crema, A; D'Angelo, L; De Ponti, F; Frigo, GM; Grimaldi, R; Guidi, G; Lecchini, S, 1990
)
0.48
"Escalating doses of intravenous AA were administered and serum concentrations were measured at multiple time points for the pharmacokinetic studies."( Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia.
Bae, ON; Baek, SH; Fitzgerald, SD; Goudreau, J; Hejabian, S; Kassab, M; Lee, KY; Majid, A; Moussa, A; Reeves, M; Rumbeiha, W; Serfozo, K; Stein, G, 2012
)
1.82
" The results suggest that the method could be applied to therapeutic monitoring of AA and pharmacokinetic studies in human volunteers."( A liquid chromatography/electrospray ionization tandem mass spectrometric method for quantification of asiatic acid from plasma: application to pharmacokinetic study in rats.
Menon, S; Nair, SN; Shailajan, S, 2012
)
0.59
" To enhance the development potentials of asiatic acid as a chemopreventative agent, there is a great need to further understand its biopharmaceutical and pharmacokinetic properties."( Biopharmaceutical and pharmacokinetic characterization of asiatic acid in Centella asiatica as determined by a sensitive and robust HPLC-MS method.
Chai, Y; Sun, F; Sun, S; Yuan, Y; Zhang, H; Zhu, Z, 2015
)
0.93
" Plasma concentrations of asiatic acid were determined at designated points and main pharmacokinetic parameters were estimated."( Biopharmaceutical and pharmacokinetic characterization of asiatic acid in Centella asiatica as determined by a sensitive and robust HPLC-MS method.
Chai, Y; Sun, F; Sun, S; Yuan, Y; Zhang, H; Zhu, Z, 2015
)
0.96
" In this study, the pharmacokinetic profiles and metabolomic changes generated by the bioactive triterpenoids of Centell-S alone, and in combination with the bioenhancers piperine and curcumin, were investigated in beagle dogs."( Bioenhancing effects of piperine and curcumin on triterpenoid pharmacokinetics and neurodegenerative metabolomes from Centella asiatica extract in beagle dogs.
Boonyarattanasoonthorn, T; Hamlin, R; Khemawoot, P; Kijtawornrat, A; Kongratanapasert, T; Maiuthed, A, 2022
)
0.72

Compound-Compound Interactions

ExcerptReferenceRelevance
" coli (UPECs), we examined its effect in combination with two pentacyclic triterpenes - asiatic and ursolic acids."( Pentacyclic triterpenes combined with ciprofloxacin help to eradicate the biofilm formed in vitro by Escherichia coli.
Kicia, M; Tichaczek-Goska, D; Wojnicz, D, 2015
)
0.42
" Ciprofloxacin combined with ursolic acid inhibited the biofilm formation on microtitre plates."( Pentacyclic triterpenes combined with ciprofloxacin help to eradicate the biofilm formed in vitro by Escherichia coli.
Kicia, M; Tichaczek-Goska, D; Wojnicz, D, 2015
)
0.42
" Pentacyclic triterpenes used in combination with ciprofloxacin enhanced its anti-biofilm effectiveness."( Pentacyclic triterpenes combined with ciprofloxacin help to eradicate the biofilm formed in vitro by Escherichia coli.
Kicia, M; Tichaczek-Goska, D; Wojnicz, D, 2015
)
0.42

Bioavailability

Asiatic acid, a well-known plant-based neuroprotective pentacyclic triterpenoid, has major limitation for its bioavailability in the brain. To enhance the oral bioavailability of asiatic Acid tromethamine salt (AAS) by encapsulation in solid lipid nanoparticles (SLN)

ExcerptReferenceRelevance
"The comparative steady-state bioavailability of asiatic acid was studied in 12 healthy male and female volunteers following oral administration of approximately equimolar doses of either asiatic acid (12 mg) or the glycoside derivative of asiatic acid, asiaticoside (24 mg)."( The comparative steady-state bioavailability of the active ingredients of Madecassol.
Graham, DJ; Murray, GR; Rush, WR,
)
0.39
" The study undertaken to analyze the drug-binding mechanisms of HSA is crucial in understanding the bioavailability of drugs."( Unraveling the binding mechanism of asiatic acid with human serum albumin and its biological implications.
Gokara, M; Kalangi, SK; Malavath, T; Reddana, P; Subramanyam, R, 2014
)
0.68
"The absolute oral bioavailability of asiatic acid is 16."( Biopharmaceutical and pharmacokinetic characterization of asiatic acid in Centella asiatica as determined by a sensitive and robust HPLC-MS method.
Chai, Y; Sun, F; Sun, S; Yuan, Y; Zhang, H; Zhu, Z, 2015
)
0.93
"The asiatic acid in a variety of matrixes was analyzed by using a sensitive and specific HPLC-MS method, and its absolute oral bioavailability in rats was very low."( Biopharmaceutical and pharmacokinetic characterization of asiatic acid in Centella asiatica as determined by a sensitive and robust HPLC-MS method.
Chai, Y; Sun, F; Sun, S; Yuan, Y; Zhang, H; Zhu, Z, 2015
)
1.22
"Asiatic acid, a well-known plant-based neuroprotective pentacyclic triterpenoid, has major limitation for its bioavailability in the brain."( Development of glutathione-conjugated asiatic acid-loaded bovine serum albumin nanoparticles for brain-targeted drug delivery.
Acharya, N; Acharya, S; Mistry, T; Raval, N, 2015
)
2.13
"The results showed 10-fold more bioavailability of asiatic acid in the brain after 5 h with glutathione-conjugated asiatic acid-loaded BSA nanoparticles as compared with asiatic acid solution with 627."( Development of glutathione-conjugated asiatic acid-loaded bovine serum albumin nanoparticles for brain-targeted drug delivery.
Acharya, N; Acharya, S; Mistry, T; Raval, N, 2015
)
0.94
"To enhance the oral bioavailability of asiatic acid tromethamine salt (AAS) by encapsulation in solid lipid nanoparticles (SLN)."( Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling, G; Weigen, L; Yuan, Z, 2016
)
0.93
"This study reveals that SLN is developed as a promising oral delivery system of AAS with significantly enhanced bioavailability and good storage stability."( Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling, G; Weigen, L; Yuan, Z, 2016
)
0.66
" Meanwhile, a low-speed single pass perfusion model of rat in situ was set up to estimate the absorption kinetics of p-AA-NLC in small intestine, where the effective permeability (Peff), absorption rate constant (Ka) and other parameters were used to evaluate the drug absorption."( [Response surface method for optimization of asiatic acid nanoparticles modified with PEG and its enhancing effects on intestinal absorption].
Huang, XY; Liang, ZH; Wang, SH; Yin, LN; Zhang, YW; Zhu, L, 2016
)
0.69
"5 times of the AA-NLC group, indicating that the oral bioavailability of AA-NLC was significantly improved by hydrophilic modification of PEG."( [Oral absorption of asiatic acid nanoparticles modified with PEG].
Chen, XX; Huang, XY; Liang, ZH; Wang, SH; Yin, LN; Zhang, YW, 2017
)
0.78
" Resultant brain bioavailability of nanoparticles with 100."( Fabrication of peptide-linked albumin nanoconstructs for receptor-mediated delivery of asiatic acid to the brain as a preventive measure in cognitive impairment: optimization, in-vitro and in-vivo evaluation.
Acharya, N; Acharya, S; Barai, P; Raval, N, 2018
)
0.7
" Nevertheless, low bioavailability due to poor solubility limits their practical application."( Asiatic Acid Glucosamine Salt Alleviates Ultraviolet B-induced Photoaging of Human Dermal Fibroblasts and Nude Mouse Skin.
Huang, J; Liu, W; Tu, T; Wang, W; Wu, X; Zhang, W; Zhou, G, 2020
)
2
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
" The bioavailability of 29 was significantly improved in comparison with its aglycon."( Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
Chen, C; Cheng, K; Dai, L; Hu, K; Li, H; Liu, L; Sun, H; Wen, X; Xu, Q; Yuan, H, 2021
)
0.62
" However, the pharmaceutical application of AA is limited by low oral bioavailability and poor targeting efficiency."( Liver-targeted delivery of asiatic acid nanostructured lipid carrier for the treatment of liver fibrosis.
Pan, JC; Tu, LL; Yin, LN; Zhang, Y; Zhang, YW; Zheng, GL, 2021
)
0.92
" Centell-S increased oral bioavailability of major triterpenoid glycosides and can be further developed into a phytopharmaceutical product."( Increase water solubility of Centella asiatica extract by indigenous bioenhancers could improve oral bioavailability and disposition kinetics of triterpenoid glycosides in beagle dogs.
Boonyarattanasoonthorn, T; Buranasudja, V; Khemawoot, P; Kijtawornrat, A; Nuengchamnong, N; Songvut, P, 2022
)
0.72

Dosage Studied

ExcerptRelevanceReference
" The time of peak plasma concentration was not affected by dosage difference or by treatment scheme."( Pharmacokinetics of the total triterpenic fraction of Centella asiatica after single and multiple administrations to healthy volunteers. A new assay for asiatic acid.
Caravaggi, M; Crema, A; D'Angelo, L; De Ponti, F; Frigo, GM; Grimaldi, R; Guidi, G; Lecchini, S, 1990
)
0.48
" To facilitate translation of these findings to clinical studies, we determined pharmacokinetics, a dose-response relationship, the therapeutic time window, and efficacy using multiple stroke models."( Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia.
Bae, ON; Baek, SH; Fitzgerald, SD; Goudreau, J; Hejabian, S; Kassab, M; Lee, KY; Majid, A; Moussa, A; Reeves, M; Rumbeiha, W; Serfozo, K; Stein, G, 2012
)
1.82
" Subsequently, a dose-response relationship was determined followed by administration at different intervals after the onset of ischemia to establish a therapeutic time window for neuroprotection."( Asiatic acid attenuates infarct volume, mitochondrial dysfunction, and matrix metalloproteinase-9 induction after focal cerebral ischemia.
Bae, ON; Baek, SH; Fitzgerald, SD; Goudreau, J; Hejabian, S; Kassab, M; Lee, KY; Majid, A; Moussa, A; Reeves, M; Rumbeiha, W; Serfozo, K; Stein, G, 2012
)
1.82
"The toxicities of conventional chemotherapeutic agents to normal cells restrict their dosage and clinical efficacy in acute leukemia; therefore, it is important to develop novel chemotherapeutics, including natural products, which selectively target cancer-specific pathways."( Apoptosis of HL-60 human leukemia cells induced by Asiatic acid through modulation of B-cell lymphoma 2 family proteins and the mitogen-activated protein kinase signaling pathway.
Chen, Y; Jiang, X; Liu, F; Lv, T; Wen, L; Wu, Q; Zhang, J, 2015
)
0.67
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
angiogenesis modulating agentAn agent that modulates the physiologic angiogenesis process. This is accomplished by endogenous angiogenic proteins and a variety of other chemicals and pharmaceutical agents.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
monocarboxylic acidAn oxoacid containing a single carboxy group.
triolA chemical compound containing three hydroxy groups.
pentacyclic triterpenoid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (11)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Aldo-keto reductase family 1 member B10Homo sapiens (human)IC50 (µMol)5.90000.00101.94459.6000AID697009
Glycogen phosphorylase, muscle formOryctolagus cuniculus (rabbit)IC50 (µMol)16.99410.01405.93249.0000AID404873; AID603224
Pancreatic alpha-amylaseSus scrofa (pig)IC50 (µMol)200.00001.35304.31088.9300AID1465050
Prostaglandin G/H synthase 1Ovis aries (sheep)IC50 (µMol)40.00000.00032.177410.0000AID1617778
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)40.00000.00011.68479.3200AID1617774
Aldo-keto reductase family 1 member B1Homo sapiens (human)IC50 (µMol)34.00000.00101.191310.0000AID697010
Tyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)IC50 (µMol)20.00000.70004.58049.4500AID409687
Tyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)IC50 (µMol)20.00000.00053.49849.7600AID409686
Prostaglandin G/H synthase 2Homo sapiens (human)IC50 (µMol)40.00000.00010.995010.0000AID1617780
DNA repair protein RAD52 homologHomo sapiens (human)IC50 (µMol)450.00000.25502.63016.7000AID1639797; AID1639799
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
G-protein coupled bile acid receptor 1Homo sapiens (human)EC50 (µMol)10.00000.02372.52598.9000AID444761
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (171)

Processvia Protein(s)Taxonomy
retinoid metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
farnesol catabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B10Homo sapiens (human)
cellular detoxification of aldehydeAldo-keto reductase family 1 member B10Homo sapiens (human)
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
retinoid metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
epithelial cell maturationAldo-keto reductase family 1 member B1Homo sapiens (human)
renal water homeostasisAldo-keto reductase family 1 member B1Homo sapiens (human)
carbohydrate metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
C21-steroid hormone biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
L-ascorbic acid biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
regulation of urine volumeAldo-keto reductase family 1 member B1Homo sapiens (human)
retinol metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of apoptotic processAldo-keto reductase family 1 member B1Homo sapiens (human)
daunorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
doxorubicin metabolic processAldo-keto reductase family 1 member B1Homo sapiens (human)
fructose biosynthetic processAldo-keto reductase family 1 member B1Homo sapiens (human)
cellular hyperosmotic salinity responseAldo-keto reductase family 1 member B1Homo sapiens (human)
metanephric collecting duct developmentAldo-keto reductase family 1 member B1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IITyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of cell population proliferationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tumor necrosis factor-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of lipid storageTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
B cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
T cell differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
erythrocyte differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of epidermal growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of tyrosine phosphorylation of STAT proteinTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
glucose homeostasisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage differentiationTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of gluconeogenesisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of inflammatory responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of T cell receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of chemotaxisTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-6-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-2-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of interleukin-4-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of macrophage colony-stimulating factor signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of positive thymic T cell selectionTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
negative regulation of receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
positive regulation of JUN kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of signal transductionTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
actin cytoskeleton organizationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of endocytosisTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of vascular endothelial growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of intracellular protein transportTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cellular response to unfolded proteinTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylationTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
platelet-derived growth factor receptor-beta signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor recyclingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of MAP kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of insulin receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of type I interferon-mediated signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
growth hormone receptor signaling pathway via JAK-STATTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of protein tyrosine kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of ERK1 and ERK2 cascadeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
regulation of hepatocyte growth factor receptor signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathwayTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of IRE1-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
negative regulation of PERK-mediated unfolded protein responseTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
positive regulation of receptor catabolic processTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 2Homo sapiens (human)
embryo implantationProstaglandin G/H synthase 2Homo sapiens (human)
learningProstaglandin G/H synthase 2Homo sapiens (human)
memoryProstaglandin G/H synthase 2Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell population proliferationProstaglandin G/H synthase 2Homo sapiens (human)
response to xenobiotic stimulusProstaglandin G/H synthase 2Homo sapiens (human)
response to nematodeProstaglandin G/H synthase 2Homo sapiens (human)
response to fructoseProstaglandin G/H synthase 2Homo sapiens (human)
response to manganese ionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vascular endothelial growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 2Homo sapiens (human)
bone mineralizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of prostaglandin biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fever generationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic plasticityProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of synaptic transmission, dopaminergicProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin secretionProstaglandin G/H synthase 2Homo sapiens (human)
response to estradiolProstaglandin G/H synthase 2Homo sapiens (human)
response to lipopolysaccharideProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of peptidyl-serine phosphorylationProstaglandin G/H synthase 2Homo sapiens (human)
response to vitamin DProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to heatProstaglandin G/H synthase 2Homo sapiens (human)
response to tumor necrosis factorProstaglandin G/H synthase 2Homo sapiens (human)
maintenance of blood-brain barrierProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of protein import into nucleusProstaglandin G/H synthase 2Homo sapiens (human)
hair cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of apoptotic processProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of nitric oxide biosynthetic processProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of cell cycleProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of vasoconstrictionProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle contractionProstaglandin G/H synthase 2Homo sapiens (human)
decidualizationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of smooth muscle cell proliferationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of inflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
response to glucocorticoidProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of calcium ion transportProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicProstaglandin G/H synthase 2Homo sapiens (human)
response to fatty acidProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to mechanical stimulusProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to lead ionProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to ATPProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to hypoxiaProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to non-ionic osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to fluid shear stressProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of transforming growth factor beta productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of cell migration involved in sprouting angiogenesisProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of fibroblast growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of brown fat cell differentiationProstaglandin G/H synthase 2Homo sapiens (human)
positive regulation of platelet-derived growth factor productionProstaglandin G/H synthase 2Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 2Homo sapiens (human)
regulation of neuroinflammatory responseProstaglandin G/H synthase 2Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stressProstaglandin G/H synthase 2Homo sapiens (human)
cellular response to homocysteineProstaglandin G/H synthase 2Homo sapiens (human)
response to angiotensinProstaglandin G/H synthase 2Homo sapiens (human)
DNA double-strand break processing involved in repair via single-strand annealingDNA repair protein RAD52 homologHomo sapiens (human)
cellular response to oxidative stressDNA repair protein RAD52 homologHomo sapiens (human)
regulation of nucleotide-excision repairDNA repair protein RAD52 homologHomo sapiens (human)
DNA recombinase assemblyDNA repair protein RAD52 homologHomo sapiens (human)
double-strand break repairDNA repair protein RAD52 homologHomo sapiens (human)
DNA recombinationDNA repair protein RAD52 homologHomo sapiens (human)
double-strand break repair via homologous recombinationDNA repair protein RAD52 homologHomo sapiens (human)
mitotic recombinationDNA repair protein RAD52 homologHomo sapiens (human)
double-strand break repair via single-strand annealingDNA repair protein RAD52 homologHomo sapiens (human)
cell surface bile acid receptor signaling pathwayG-protein coupled bile acid receptor 1Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeG-protein coupled bile acid receptor 1Homo sapiens (human)
cellular response to bile acidG-protein coupled bile acid receptor 1Homo sapiens (human)
positive regulation of cholangiocyte proliferationG-protein coupled bile acid receptor 1Homo sapiens (human)
regulation of bicellular tight junction assemblyG-protein coupled bile acid receptor 1Homo sapiens (human)
G protein-coupled receptor signaling pathwayG-protein coupled bile acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (44)

Processvia Protein(s)Taxonomy
retinal dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldo-keto reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B10Homo sapiens (human)
alcohol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
geranylgeranyl reductase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
indanol dehydrogenase activityAldo-keto reductase family 1 member B10Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B10Homo sapiens (human)
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
retinal dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
aldose reductase (NADPH) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein bindingAldo-keto reductase family 1 member B1Homo sapiens (human)
electron transfer activityAldo-keto reductase family 1 member B1Homo sapiens (human)
prostaglandin H2 endoperoxidase reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glyceraldehyde oxidoreductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
allyl-alcohol dehydrogenase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
L-glucuronate reductase activityAldo-keto reductase family 1 member B1Homo sapiens (human)
glycerol dehydrogenase [NADP+] activityAldo-keto reductase family 1 member B1Homo sapiens (human)
all-trans-retinol dehydrogenase (NADP+) activityAldo-keto reductase family 1 member B1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
integrin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
syntaxin bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
STAT family protein bindingTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
RNA bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
insulin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
zinc ion bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
enzyme bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
receptor tyrosine kinase bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cadherin bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
ephrin receptor bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein phosphatase 2A bindingTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
non-membrane spanning protein tyrosine phosphatase activityTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
peroxidase activityProstaglandin G/H synthase 2Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 2Homo sapiens (human)
protein bindingProstaglandin G/H synthase 2Homo sapiens (human)
enzyme bindingProstaglandin G/H synthase 2Homo sapiens (human)
heme bindingProstaglandin G/H synthase 2Homo sapiens (human)
protein homodimerization activityProstaglandin G/H synthase 2Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 2Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 2Homo sapiens (human)
DNA bindingDNA repair protein RAD52 homologHomo sapiens (human)
single-stranded DNA bindingDNA repair protein RAD52 homologHomo sapiens (human)
protein bindingDNA repair protein RAD52 homologHomo sapiens (human)
identical protein bindingDNA repair protein RAD52 homologHomo sapiens (human)
protein bindingG-protein coupled bile acid receptor 1Homo sapiens (human)
bile acid receptor activityG-protein coupled bile acid receptor 1Homo sapiens (human)
G protein-coupled bile acid receptor activityG-protein coupled bile acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (34)

Processvia Protein(s)Taxonomy
extracellular regionAldo-keto reductase family 1 member B10Homo sapiens (human)
lysosomeAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B10Homo sapiens (human)
mitochondrionAldo-keto reductase family 1 member B10Homo sapiens (human)
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spaceAldo-keto reductase family 1 member B1Homo sapiens (human)
nucleoplasmAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
extracellular exosomeAldo-keto reductase family 1 member B1Homo sapiens (human)
cytosolAldo-keto reductase family 1 member B1Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartmentTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
nucleusTyrosine-protein phosphatase non-receptor type 2Homo sapiens (human)
plasma membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial matrixTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytosolTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
mitochondrial cristaTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endosome lumenTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
sorting endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmic side of endoplasmic reticulum membraneTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
protein-containing complexTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
endoplasmic reticulumTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
cytoplasmTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
early endosomeTyrosine-protein phosphatase non-receptor type 1Homo sapiens (human)
nuclear inner membraneProstaglandin G/H synthase 2Homo sapiens (human)
nuclear outer membraneProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulumProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum lumenProstaglandin G/H synthase 2Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 2Homo sapiens (human)
caveolaProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
protein-containing complexProstaglandin G/H synthase 2Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 2Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 2Homo sapiens (human)
nucleusDNA repair protein RAD52 homologHomo sapiens (human)
nucleoplasmDNA repair protein RAD52 homologHomo sapiens (human)
protein-containing complexDNA repair protein RAD52 homologHomo sapiens (human)
protein-DNA complexDNA repair protein RAD52 homologHomo sapiens (human)
nucleusDNA repair protein RAD52 homologHomo sapiens (human)
cytoplasmG-protein coupled bile acid receptor 1Homo sapiens (human)
plasma membraneG-protein coupled bile acid receptor 1Homo sapiens (human)
receptor complexG-protein coupled bile acid receptor 1Homo sapiens (human)
plasma membraneG-protein coupled bile acid receptor 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (117)

Assay IDTitleYearJournalArticle
AID1422358Cytotoxicity against mouse NIH/3T3 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID492133Induction of NEP levels in Sprague-Dawley rat primary cortical neurons at 5 uM after 24 hrs by immunoblot analysis2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID1422359Cytotoxicity against human 518A2 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1250813Antiproliferative activity against human MCF7 cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID1435537Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 50 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1617781Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis r2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1291389Cytotoxicity against human A375 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, May-23, Volume: 114Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
AID1291384Cytotoxicity against human Jurkat cells after 72 hrs by XTT assay2016European journal of medicinal chemistry, May-23, Volume: 114Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
AID1435539Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 2 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID325974Antibacterial activity against Pseudomonas aeruginosa PAO12007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
AID1465051Inhibition of yeast alpha-glucosidase using 4-nitrophenyl-alpha-D-glucopyranoside as substrate preincubated for 15 mins followed by substrate addition measured after 20 mins2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID1161324Cytotoxicity against human HeLa cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents.
AID1617777Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1424344Cytotoxicity in HUVEC cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1424292Cytotoxicity in human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID492125Reduction of BACE1 expression in Sprague-Dawley rat primary cortical neurons after 24 hrs by immunoblot analysis2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID1291382Cytotoxicity against human HT-29 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, May-23, Volume: 114Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
AID1728066Activation of AMPK in human Huh-7 cells assessed as increase in AMPK phosphorylation at Thr172 residue at 10 uM measured after 12 hrs by Western blot analysis2021European journal of medicinal chemistry, Jan-01, Volume: 209Synthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid.
AID325979Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction of bacterial count at 50 ug/ml by CDC biofilm reactor method2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
AID1617778Inhibition of ovine recombinant COX1 assessed as decrease in formation of PGE2 using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1158457Enhancement of GLUT4 translocation in rat L6 cells expressing pIRAP-mOrange cDNAs at 10 uM after 10 mins by fluorescence assay relative to control2014Bioorganic & medicinal chemistry letters, Jul-15, Volume: 24, Issue:14
Chemical constituents from Eucalyptus citriodora Hook leaves and their glucose transporter 4 translocation activities.
AID1637936Cytotoxicity against human HL-7702 cells after 48 hrs by MTT assay2019MedChemComm, Apr-01, Volume: 10, Issue:4
Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.
AID1161326Cytotoxicity against human HUVEC cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents.
AID1868239Inhibition of recombinant human SENP1 assessed as reduction in deSUMOylation of RanGAP1-SUMO1 at 5 uM using RanGAP1-SUMO1 as substrate preincubated for 10 mins followed by substrate addition and measured after 30 mins relative to control2022Journal of natural products, 05-27, Volume: 85, Issue:5
Discovery of Natural Ursane-type SENP1 Inhibitors and the Platinum Resistance Reversal Activity Against Human Ovarian Cancer Cells: A Structure-Activity Relationship Study.
AID1435541Cytotoxicity against mouse RAW264.7 cells assessed as growth inhibition at 10 uM after 72 hrs by MTT assay relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1637923Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2019MedChemComm, Apr-01, Volume: 10, Issue:4
Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.
AID1424342Cytotoxicity in human T24 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1422360Cytotoxicity against human HT-29 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1435540Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 0.4 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1424341Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID697009Inhibition of reductase activity of N-terminal 6His-tagged human AKR1B10 expressed in Escherichia coli BL21(DE3) assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID1637934Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay2019MedChemComm, Apr-01, Volume: 10, Issue:4
Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.
AID492132Induction of NEP levels in Sprague-Dawley rat primary cortical neurons at 10 uM after 24 hrs by immunoblot analysis2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID1291385Cytotoxicity against human PC3 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, May-23, Volume: 114Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
AID1250814Antiproliferative activity against human HeLa cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID492122Cytotoxicity against Sprague-Dawley rat primary cortical neurons assessed as cell death at 10 uM after 24 hrs by MAP2 immunostaining2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID587673Antibacterial activity against Staphylococcus aureus assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1424336Cytotoxicity in human HeLa cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1424293Cytotoxicity in human HT-29 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1424331Cytotoxicity in human MDA-MB-231 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID587674Antibacterial activity against Enterococcus faecalis assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1291390Cytotoxicity against human BJ cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, May-23, Volume: 114Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
AID325978Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction of bacterial count at 100 ug/ml by rotating disk reactor method2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
AID578570Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as nitrite level at 1 to 100 uM after 24 hrs by Griess method2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID325977Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction of bacterial count at 50 ug/ml by rotating disk reactor method2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
AID325976Antibacterial activity against Pseudomonas aeruginosa PAO1 assessed as log reduction of bacterial count at 10 ug/ml by rotating disk reactor method2007Antimicrobial agents and chemotherapy, May, Volume: 51, Issue:5
Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
AID1422357Cytotoxicity against human A2780 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1422361Cytotoxicity against human MCF7 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID402091Antiviral activity against HIV1 3B in human H9 cells after 4 days by p24 antigen ELISA1998Journal of natural products, Sep, Volume: 61, Issue:9
Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids.
AID1250815Antiproliferative activity against human A549 cells after 48 hrs by CCK-8 assay2015Bioorganic & medicinal chemistry letters, Oct-15, Volume: 25, Issue:20
Design, synthesis, and biofunctional evaluation of novel pentacyclic triterpenes bearing O-[4-(1-piperazinyl)-4-oxo-butyryl moiety as antiproliferative agents.
AID1637933Cytotoxicity against human A549 cells after 48 hrs by MTT assay2019MedChemComm, Apr-01, Volume: 10, Issue:4
Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.
AID492129Induction of IDE levels in Sprague-Dawley rat primary cortical neurons at 5 to 100 uM after 24 hrs by immunoblot analysis2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID1291386Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, May-23, Volume: 114Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
AID1435538Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha production at 10 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID402092Cytotoxicity against mock-infected human H9 cells after 4 days1998Journal of natural products, Sep, Volume: 61, Issue:9
Anti-AIDS agents. 30. Anti-HIV activity of oleanolic acid, pomolic acid, and structurally related triterpenoids.
AID1617779Inhibition of ovine recombinant COX1 assessed as residual activity at 42 uM using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1422362Cytotoxicity against human A549 cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID1435530Cytotoxicity against human NCI-N87 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1161321Cytotoxicity against human MGC803 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents.
AID1637922Cytotoxicity against human T24 cells after 48 hrs by MTT assay2019MedChemComm, Apr-01, Volume: 10, Issue:4
Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.
AID587675Antibacterial activity against Escherichia coli assessed as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1424343Cytotoxicity in human SPCA2 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID409686Inhibition of PTP1B by pNPP assay2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID404873Inhibition of rabbit muscle glycogen phosphorylase A assessed as phosphate release from glucose-1-phosphate2008Journal of medicinal chemistry, Jun-26, Volume: 51, Issue:12
Naturally occurring pentacyclic triterpenes as inhibitors of glycogen phosphorylase: synthesis, structure-activity relationships, and X-ray crystallographic studies.
AID492124Cytotoxicity against Sprague-Dawley rat primary cortical neurons assessed as cell morphology at 10 uM after 24 hrs by MAP2 immunostaining2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID1291383Cytotoxicity against human HeLa cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, May-23, Volume: 114Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
AID1637955Toxicity in human A549 cells assessed as reduction in cell viability2019MedChemComm, Apr-01, Volume: 10, Issue:4
Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.
AID492131Induction of NEP levels in Sprague-Dawley rat primary cortical neurons at 1 uM after 24 hrs by immunoblot analysis2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID444761Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID603224Inhibition of rabbit muscle glycogen phosphorylase A assessed as release of phosphate from glucose-1-phosphate after 25 mins by microplate reader based method2011European journal of medicinal chemistry, Jun, Volume: 46, Issue:6
Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
AID1666863Inhibition of swarming motility of Pseudomonas aeruginosa HONKR at 16 ug/mL incubated for 16 to 20 hrs relative to control2020Bioorganic & medicinal chemistry, 03-01, Volume: 28, Issue:5
Optimized plant compound with potent anti-biofilm activity across gram-negative species.
AID1424338Cytotoxicity in human PC3 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1161325Cytotoxicity against human SMMC-7404 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents.
AID492126Induction of ADAM10 activation in Sprague-Dawley rat primary cortical neurons after 24 hrs by immunoblot analysis2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID1424334Cytotoxicity in human A549 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID1617774Inhibition of human recombinant 5-LOX expressed in insect cells assessed as decrease in production of 5-HPETE and 5-HETE using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric io2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1617775Inhibition of human recombinant 5-LOX expressed in insect cells assessed residual activity using arachidonic acid at 42 uM as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol o2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1291388Cytotoxicity against human MIAPaCa2 cells after 72 hrs by MTT assay2016European journal of medicinal chemistry, May-23, Volume: 114Synthesis and anticancer activity of novel fluorinated asiatic acid derivatives.
AID1435536Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 0.4 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1435534Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 10 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID578568Cytotoxicity against mouse RAW264.7 cells assessed as cell viability by MTT assay2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID1424330Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 48 hrs by SRB assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID492121Cytotoxicity against Sprague-Dawley rat primary cortical neurons assessed as cell death at 100 uM after 24 hrs by MAP2 immunostaining2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID1435533Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 50 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1422363Cytotoxicity against human 8505C cells after 96 hrs by sulforhodamine B assay2018European journal of medicinal chemistry, Nov-05, Volume: 159Transformation of asiatic acid into a mitocanic, bimodal-acting rhodamine B conjugate of nanomolar cytotoxicity.
AID578565Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID391574Antiproliferative activity against mouse +SA mammary epithelial cells after 4 days by MTT assay2008Journal of natural products, Oct, Volume: 71, Issue:10
Antiproliferative triterpenes from Melaleuca ericifolia.
AID1424335Cytotoxicity in human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID697010Inhibition of reductase activity of N-terminal 6His-tagged human recombinant AKR1B1 expressed in Escherichia coli BL21(DE3) assessed as assessed as pyridine-3-aldehyde reduction2011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID444763Agonist activity at human FXR expressed in COS1 cells by luciferase reporter gene assay2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID1435529Cytotoxicity against human HepG2 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1161322Cytotoxicity against human NCI-H460 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents.
AID492127Induction of matured ADAM10 level in Sprague-Dawley rat primary cortical neurons after 24 hrs by immunoblot analysis2010Journal of natural products, Jul-23, Volume: 73, Issue:7
Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance.
AID578664Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as TNF-alpha level at 1 to 100 uM after 18 hrs2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID587676Antibacterial activity against Pseudomonas aeruginosa as growth inhibition by liquid microdilution assay2011Journal of natural products, Feb-25, Volume: 74, Issue:2
Triterpenoid saponins from Symplocos lancifolia.
AID1637924Inhibition of NFkappaB (unknown origin) expressed in human A549 cells co-transfected with pNFkappaB-Luc vector assessed as reduction in TNFalpha-induced NFkappaB transcriptional activity co-incubated for 7 hrs in presence of TNFalpha by bright-glo lucifer2019MedChemComm, Apr-01, Volume: 10, Issue:4
Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.
AID1435535Anti-inflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced IL-6 production at 2 uM pretreated for 1 hr followed by LPS stimulation measured after 24 hrs by ELISA relative to control2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID1435531Cytotoxicity against human MCF7 cells after 72 hrs by MTT assay2016Journal of natural products, 11-23, Volume: 79, Issue:11
Bioactive Pentacyclic Triterpenoids from the Leaves of Cleistocalyx operculatus.
AID697011Selectivity ratio of IC50 for human recombinant AKR1B1 to IC50 for human AKR1B102011Journal of natural products, May-27, Volume: 74, Issue:5
Selective inhibition of the tumor marker aldo-keto reductase family member 1B10 by oleanolic acid.
AID38498In vitro percent protective effect against Amyloid Beta(A beta)-induced neurotoxicity in B103 cells2000Bioorganic & medicinal chemistry letters, Jan-17, Volume: 10, Issue:2
Structure-activity relationship study of asiatic acid derivatives against beta amyloid (A beta)-induced neurotoxicity.
AID444762Agonist activity at TGR5 expressed in CHO cells by CRE-driven luciferase reporter gene assay relative to litocholic acid2010Journal of medicinal chemistry, Jan-14, Volume: 53, Issue:1
Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes.
AID1637935Cytotoxicity against human NCI-H460/DOX cells after 48 hrs by MTT assay2019MedChemComm, Apr-01, Volume: 10, Issue:4
Synthesis and discovery of asiatic acid based 1,2,3-triazole derivatives as antitumor agents blocking NF-κB activation and cell migration.
AID1617776Inhibition of human recombinant N-terminal His-tagged 15-LOX2 expressed in Escherichia coli using arachidonic acid as substrate preincubated for 5 mins followed by substrate addition measured after 20 mins in dark by ferric ion oxidation-xylenol orange as2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID578564Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess method2011Bioorganic & medicinal chemistry letters, Mar-15, Volume: 21, Issue:6
A new ursane-type triterpenoid glycoside from Centella asiatica leaves modulates the production of nitric oxide and secretion of TNF-α in activated RAW 264.7 cells.
AID1617780Inhibition of human recombinant COX2 expressed in baculovirus infected sf21 cells assessed as decrease in PGE2 formation using arachidonic acid as substrate preincubated for 10 mins followed by substrate addition measured after 45 mins by LC-MS analysis2019Journal of natural products, 12-27, Volume: 82, Issue:12
Structure-Activity Relationships of Pentacyclic Triterpenoids as Inhibitors of Cyclooxygenase and Lipoxygenase Enzymes.
AID1424337Cytotoxicity in human SGC7901 cells assessed as reduction in cell viability incubated for 72 hrs by CCK8 assay2017European journal of medicinal chemistry, Dec-15, Volume: 142Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID409687Inhibition of TCPTP by pNPP assay2008Bioorganic & medicinal chemistry, Sep-15, Volume: 16, Issue:18
Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities.
AID1465050Inhibition of porcine pancreatic alpha-amylase using starch as substrate preincubated for 15 mins followed by substrate addition measured after 10 mins by dinitrosalicylic acid reagent based assay2017Bioorganic & medicinal chemistry letters, 11-15, Volume: 27, Issue:22
Pentacyclic triterpenes as α-glucosidase and α-amylase inhibitors: Structure-activity relationships and the synergism with acarbose.
AID1161323Cytotoxicity against human HepG2 cells after 48 hrs by MTT assay2014European journal of medicinal chemistry, Oct-30, Volume: 86Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (286)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (1.75)18.7374
1990's8 (2.80)18.2507
2000's35 (12.24)29.6817
2010's156 (54.55)24.3611
2020's82 (28.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 53.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index53.31 (24.57)
Research Supply Index5.68 (2.92)
Research Growth Index5.50 (4.65)
Search Engine Demand Index83.18 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (53.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (1.04%)5.53%
Reviews8 (2.77%)6.00%
Case Studies2 (0.69%)4.05%
Observational0 (0.00%)0.25%
Other276 (95.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]